Connor, Clark & Lunn Investment Management (CC&L)’s Entrada Therapeutics TRDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,553
| Closed | -$104K | – | 1687 |
|
|
2025
Q1 | $104K | Sell |
11,553
-74,068
| -87% | -$670K | ﹤0.01% | 1350 |
|
|
2024
Q4 | $1.48M | Sell |
85,621
-52,984
| -38% | -$916K | 0.01% | 812 |
|
|
2024
Q3 | $2.21M | Buy |
138,605
+78,953
| +132% | +$1.26M | 0.01% | 644 |
|
|
2024
Q2 | $850K | Buy |
59,652
+28,868
| +94% | +$411K | ﹤0.01% | 888 |
|
|
2024
Q1 | $436K | Buy |
+30,784
| New | +$436K | ﹤0.01% | 1154 |
|